Your Training Is Dialed In.
Your Stack Should Be Too.

The Muscle, Energy and Mental Acuity Protocol is a physician supervised microdose protocol that combines tirzepatide with NAD+, L-Carnitine, and methylcobalamin (B12). It is designed for patients whose goals span muscle preservation, physical recovery, sustained energy, and cognitive output. A board certified MD or DO reviews your intake within 24 hours, prescribes a starting protocol calibrated to your biology, and the full protocol is shipped from a licensed US pharmacy. The protocol requires no clinic visits and includes optional lab monitoring at 12 and 26 weeks.

Microdose tirzepatide uses a fraction of the labeled injectable dose and titrates by individual response rather than a fixed manufacturer schedule. Standard injectable tirzepatide dosing is calibrated for maximum weight loss in adults with clinical obesity at higher doses titrated weekly. Published dose ranging data show that GI side effects fall sharply at lower doses while central GLP-1 receptor activation, which governs satiety and metabolic signaling, is preserved. The result for most patients is meaningful body composition change with a substantially gentler tolerability profile. Individual results vary.

Each component addresses a distinct part of the metabolic foundation underneath training and recovery. L-Carnitine moves long chain fatty acids into the mitochondria for fuel, the rate limiting step in fat oxidation, and helps clear the byproducts that contribute to post exercise soreness. NAD+ supports mitochondrial energy production and cellular repair, both of which decline measurably with age. Methylcobalamin, the active form of B12, bypasses the MTHFR dependent conversion that cyanocobalamin requires and supports the neural repair that should occur during deep sleep. Together with microdose tirzepatide, the protocol targets metabolic signaling, fuel use, recovery, and cognitive output in parallel.

GLP-1 receptors are expressed in the hippocampus and cortex, where they are involved in insulin signaling, neuroinflammation, and synaptic plasticity. Published research on standard injectable GLP-1 has documented cognitive findings in trials of patients with mild cognitive impairment and post-COVID cognitive symptoms, including changes in processing speed and working memory. Microdose compounded protocols target central GLP-1 receptor activation; the cognitive rationale is mechanistic and supported by full dose trial data. Dedicated microdose RCTs in cognitive performance are limited and individual results vary. All prescribing decisions are made by the supervising physician based on your clinical profile.

Brain fog is associated with multiple distinct mechanisms including suboptimal B12, insulin dysregulation, neuroinflammation, post-viral cognitive symptoms, and perimenopausal hormonal shifts. The protocol is designed to address several of these in parallel: methylcobalamin supports active B12 levels; NAD+ supports mitochondrial energy in neurons; L-Carnitine supports clearance of acylcarnitines that accumulate under cognitive load; compounded microdose tirzepatide may support central GLP-1 receptor signaling. Many patients report subjective changes within the first two to four weeks, though the underlying causes of brain fog vary and not every patient responds equally. Individual results will vary.

Yes. Perimenopause is associated with measurable changes in processing speed, working memory, and word retrieval. The mechanisms include declining estrogen driven neuroinflammation, insulin sensitivity changes, and disrupted sleep architecture. Compounded microdose tirzepatide may support the metabolic and neuroinflammatory components of these symptoms; the protocol as a whole is designed to support cognitive endurance during the transition. The protocol is generally compatible with HRT for women already on it. Pregnancy and planned pregnancy are contraindications. Your physician evaluates whether the protocol is appropriate for your specific presentation. Individual results will vary.

Most patients report subjective changes in mental clarity, motivation, and mid-afternoon energy within the first two to four weeks. Sustained cognitive endurance under high load typically becomes noticeable at six to ten weeks. Lab improvements such as B12 levels, fasting insulin, and HbA1c generally appear at the 12 week retest. Individual results will vary based on baseline metabolic state, dose response, sleep adherence, and other factors.

Compounded tirzepatide at microdose levels is not FDA approved as a specific product or indication. The active compound has been studied through Phase 3 trials at higher doses, where its safety profile is well characterized. Compounded tirzepatide is prescribed by licensed physicians at lower doses through licensed compounding pharmacies, which is a recognized clinical use under physician supervision. Specific microdose efficacy data is drawn from published dose ranging studies rather than dedicated microdose RCTs. Your prescribing physician evaluates whether a microdose protocol is clinically appropriate for your situation.

Yes, the protocol is designed for body composition optimization rather than weight loss alone, and many patients have a BMI in the normal or slightly elevated range. The protocol's primary outcomes are muscle preservation during caloric deficit, faster recovery between training sessions, improved insulin sensitivity, and sustained energy. For lean patients, weight on the scale may shift only modestly while waist circumference, lean mass percentage, and energy markers improve meaningfully. Your physician evaluates whether the protocol is appropriate based on your specific goals, baseline labs, and clinical profile. Individual results vary.

Lean mass preservation is a primary design goal of the protocol. Conventional caloric restriction and full dose GLP-1 therapy can both produce meaningful lean mass loss, particularly in adults over 40. The protocol addresses this through three mechanisms: microdose tirzepatide produces a more gradual caloric deficit than full dose injectable therapy, L-Carnitine supports the metabolic pathways that prefer fat over lean tissue for fuel, and protocol guidance emphasizes 1.6 to 1.8 grams of protein per kilogram of body weight daily plus resistance training two to three times weekly. Lean mass tracking is part of the optional 12 and 26 week retest.

There are three meaningful differences. First, tirzepatide requires a physician prescription and is the anchor of the protocol, so the OTC path cannot include it. Second, the components are sourced from licensed pharmacies at pharmaceutical grade purity with documented potency, rather than the wide variability common in supplement grade products. Third, the protocol includes physician evaluation, drug interaction review, and optional lab monitoring, none of which is available with self directed OTC use. The protocol is calibrated to your biology by a board certified MD or DO, not assigned at a manufacturer default dose.

Microdose protocols consistently show a lower incidence of the GI side effects that drive most discontinuations of full dose injectable tirzepatide. Published dose ranging data and clinical experience suggest nausea rates of roughly 5 to 12 percent at microdose levels compared to 25 to 45 percent at full label doses, with similar reductions in reflux, constipation, and early satiety. Other potential effects include mild fatigue during titration, headache, and rare hypersensitivity reactions, and the safety considerations of full dose tirzepatide including pancreatitis history, MTC or MEN2 contraindication, and gallbladder concerns all still apply. Side effects are reviewed at intake and monitored throughout the protocol. Individual results vary.

Yes, tirzepatide requires a physician prescription, and NAD+, L-Carnitine, and B12 are included as part of the supervised protocol. Your assigned board certified MD or DO reviews your intake within 24 hours, evaluates contraindications, and prescribes your starting protocol. The full protocol ships from a licensed pharmacy directly to your door. Monitoring is asynchronous through secure messaging with your physician for adjustments, and optional lab retesting at 12 and 26 weeks tracks HbA1c, fasting glucose, lipids, and other markers your physician selects. There are no required clinic visits.

Generally yes, with physician coordination. Tirzepatide does not have known significant pharmacokinetic interactions with testosterone replacement therapy, and many patients on TRT use this protocol concurrently for body composition support that TRT alone does not fully provide. The same applies to common medications like metformin, statins, antihypertensives, and SSRIs, with most being compatible after appropriate clinical review. Your physician examines your full medication list at intake and flags any concerns specific to your situation. If you take insulin, sulfonylureas, or warfarin, additional monitoring is typical.

Most patients report subjective changes in energy, food noise, and recovery within the first two to four weeks of starting the protocol. Body composition changes including lean mass percentage, waist circumference, and weight typically become measurable at eight to twelve weeks. Lab improvements such as HbA1c, fasting insulin, and lipid panel generally appear at the 12 week retest, with continued progression through 26 weeks. The exact trajectory depends on baseline metabolic state, dose response, training consistency, and protein adherence. A small percentage of patients are non responders, identified by week 8, and the protocol is adjusted or reconsidered at that point. Individual results vary.

This protocol is a direct pay monthly subscription and is not currently billed through insurance. Standard injectable tirzepatide is covered by some insurance plans, but compounded microdose protocols typically are not. Some patients use HSA or FSA accounts for the medical visit portion of the protocol, depending on plan rules. Pricing is transparent and posted on the protocol page, with no surprise charges, no separate consult fees, and no long term commitment. You can pause or cancel at any time.